PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston.\', \'Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.\', \'Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamaoncol.2021.5148
?:hasPublicationType
?:journal
  • JAMA oncology
is ?:pmid of
?:pmid
?:pmid
  • 34709356
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.187
?:rankingScore_hIndex
  • 41
?:title
  • Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all